The increasing attention on personalized breast cancer care has resulted in an explosion of
new interactive, tailored, web-based clinical decision tools for guiding treatment decisions in …

Simple Summary Ductal carcinoma in situ (DCIS) is a potential precursor to invasive breast
cancer (IBC). Although in many women DCIS will never become breast cancer, almost all …

Background The landscape of clinical trials testing risk-adapted modulations of cancer
treatments is complex. Multiple trial designs, endpoints, and thresholds for non-inferiority …

Background The increased availability of patient reported outcome data makes it feasible to
provide patients tailored risk information of cancer treatment side effects. However, it is …

Background: Disclosure of cancer statistics (eg, survival or incidence rates) based on a
representative group of patients can help increase cancer survivors' understanding of their …

Over the last years, the use of Internet of Things (IoT) systems in healthcare has increased
due to technological advancements and increased availability of data. Sensor-based …

Objective We investigated how healthcare professionals (HPs) communicate personalized
risks of treatment side-effects to patients with localized prostate cancer during consultations …

Purpose The aim of this study was to develop a patient decision aid (pDA) that could support
patients with breast cancer (BC) in making an informed decision about breast reconstruction …

In the context of shared decision‐making (SDM), experts have advocated the use of
validated decision aids (DAs) as valuable tools for facilitating SDM in various healthcare …

Background The internet allows patients to easily look for health information. However, how
Chinese patients with breast cancer use the internet has rarely been investigated, and there …